Showing 41 - 60 results of 1,388 for search '"Neoplasm"', query time: 0.05s Refine Results
  1. 41

    A Unique Case of Low-Grade Mucinous Neoplasm in Stump Appendectomy by Mohannad Al-Tarakji, Syed Muhammad Ali, Amjad Ali Shah, Mahir Abdulla Petkar, Salman Mirza, Rajvir Singh, Ahmad Zarour

    Published 2020-01-01
    “…Management of low-grade appendiceal mucinous neoplasm (LAMN) is controversial, and we discuss the importance of the case. …”
    Get full text
    Article
  2. 42
  3. 43
  4. 44

    Solid Pseudopapillary Neoplasm of the Pancreas in Young Male Patients: Three Case Reports by Akira Aso, Eikichi Ihara, Kazuhiko Nakamura, Irina Sudovykh, Tetsuhide Ito, Masafumi Nakamura, Tetsuo Ikeda, Nobuyoshi Takizawa, Yoshinao Oda, Shuji Shimizu

    Published 2017-01-01
    “…A preoperative diagnosis of solid pseudopapillary neoplasms (SPNs) in young male patients is difficult to achieve using radiological images. …”
    Get full text
    Article
  5. 45

    Concordance of Peripheral Blood and Bone Marrow Next-Generation Sequencing in Hematologic Neoplasms by Chayanit Jumniensuk, Alexander Nobori, Thomas Lee, T. Niroshi Senaratne, Dinesh Rao, Sheeja Pullarkat

    Published 2022-01-01
    “…Lymphoid neoplasms showed concordant results in 26/31 cases (83.9%) with a kappa coefficient of 0.599. …”
    Get full text
    Article
  6. 46

    Clinical Factors of Delayed Perforation after Endoscopic Submucosal Dissection for Gastric Neoplasms by Yoshinobu Yamamoto, Hogara Nishisaki, Hideki Sakai, Nagahiro Tokuyama, Hiroaki Sawai, Aya Sakai, Takuya Mimura, Saeko Kushida, Hidetaka Tsumura, Takeshi Sakamoto, Ikuya Miki, Masahiro Tsuda, Hideto Inokuchi

    Published 2017-01-01
    “…Delayed perforation is a rare but severe complication of endoscopic submucosal dissection (ESD) for early gastric neoplasm (EGN). The aim of this study was to clarify clinical factors related to delayed perforation after ESD. …”
    Get full text
    Article
  7. 47

    Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia by Georgios Petros Barakos, Vasileios Georgoulis, Epameinondas Koumpis, Eleftheria Hatzimichael

    Published 2025-01-01
    “…This is essential for understanding cancer evolution, progression, and the efficacy of immunotherapies. Myelodysplastic neoplasms (MDS) and acute myeloid leukemia (AML) are hematological neoplasms that are characterized by immune evasion mechanisms, with immunotherapy giving only modest results thus far. …”
    Get full text
    Article
  8. 48

    Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms by Vladan P. Čokić, Olivera Mitrović-Ajtić, Bojana B. Beleslin-Čokić, Dragana Marković, Marijana Buač, Miloš Diklić, Nada Kraguljac-Kurtović, Svetozar Damjanović, Pavle Milenković, Mirjana Gotić, Puri K. Raj

    Published 2015-01-01
    “…The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflammation can be more beneficial than targeting gene mutants. …”
    Get full text
    Article
  9. 49

    Mucinous Cystic Neoplasm of the Liver Mimicking as Hydatid Cyst: A Case Report by Ranjita Panigrahi, Ajit Kumar Singh, Arlene Bhuyan, Amaresh Mishra, Subrat Kumar Sahu

    Published 2025-01-01
    “…Mucinous Cystic Neoplasms (MCNs) of the liver are rare cystic tumours, accounting for less than 5% of all liver cysts. …”
    Get full text
    Article
  10. 50

    Impact of Age on Short- and Long-Term Outcomes after Pancreatoduodenectomy for Periampullary Neoplasms by Mario Gruppo, Francesca Tolin, Boris Franzato, Pierluigi Pilati, Ylenia Camilla Spolverato, Francesca Zingales, Imerio Angriman, Romeo Bardini

    Published 2020-01-01
    “…Methods. 124 consecutive patients who have undergone PD for pancreas neoplasms in our center between 2012 and 2017 were analyzed. …”
    Get full text
    Article
  11. 51
  12. 52

    The diagnostic value of MSCT and MR imaging in intraductal papillary neoplasm of the bile duct by Chao Zhang, Chengcheng Wang, Shengnan Yin, Jing Chi

    Published 2025-02-01
    Subjects: “…Intraductal papillary neoplasm of the bile duct (IPNB)…”
    Get full text
    Article
  13. 53
  14. 54
  15. 55
  16. 56

    Two Cases of Severe Hypertension in JAK2 Mutation-Positive Myeloproliferative Neoplasms by Raunak Rao, Spoorthy Kulkarni, Ian B. Wilkinson

    Published 2020-01-01
    “…Hyperviscosity and constitutive JAK-STAT activation are amongst the proposed pathophysiology linking myeloproliferative neoplasms and hypertension. Further experimental and clinical research is necessary to identify and understand possible interactions between BP and myeloproliferative neoplasms.…”
    Get full text
    Article
  17. 57

    Serum Levels of Irisin and Omentin-1 in Breast Neoplasms and Their Association with Tumor Histology by Grigorios Panagiotou, Sofia Triantafyllidou, Basil C. Tarlatzis, Eleni Papakonstantinou

    Published 2021-01-01
    “…In this study, we aimed to evaluate omentin-1 and irisin levels in women with benign and/or malignant breast neoplasms vs. healthy controls. Disease-free individuals (N = 56) and patients with histologically proven benign (N = 61) or malignant tumor (N = 96; subdivided into recently diagnosed/treatment-naïve (N = 72) and chemotherapy-treated (N = 24) subgroups) were enrolled in this study. …”
    Get full text
    Article
  18. 58

    The Implications of Liver Biopsy Results in Patients with Myeloproliferative Neoplasms Being Treated with Ruxolitinib by Douglas Tremblay, Juan Putra, Alexander Vogel, Adam Winters, Ronald Hoffman, Thomas D. Schiano, Maria Isabel Fiel, John O. Mascarenhas

    Published 2019-01-01
    “…We performed a retrospective review of hepatic damage occurring in patients with myeloproliferative neoplasms receiving ruxolitinib. Relevant histologic images of liver biopsies were reviewed by an experienced liver pathologist and reported to a multidisciplinary team including hepatology and hematology. …”
    Get full text
    Article
  19. 59
  20. 60

    RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia by Tim Kong, Angelo B. A. Laranjeira, Christopher T. Letson, LaYow Yu, Shuyang Lin, Jared S. Fowles, Daniel A. C. Fisher, Sherwin Ng, Wei Yang, Fan He, Minyoung Youn, Kailen Mark, Ana San Jose, Jingxian Liu, Alexander B. Kim, Maggie J. Cox, Mary C. Fulbright, Aarthi Jayanthan, Gerrit Los, Stacey L. Rentschler, Li Ding, Kathleen M. Sakamoto, Sandra E. Dunn, Grant A. Challen, Stephen T. Oh

    Published 2025-01-01
    “…Here, we establish a comprehensive transcriptional atlas across the spectrum of myeloproliferative neoplasms (MPN) and secondary acute myeloid leukemia (sAML) through RNA-sequencing of 158 primary samples encompassing CD34+ hematopoietic stem/progenitor cells and CD14+ monocytes. …”
    Get full text
    Article